GCC Generic Injectables Market Size, Industry Analysis, Share, Price, Research Report 2022-2027

The GCC generic injectables market reached US$ 525.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,199.7 Million by 2027, exhibiting a growth rate (CAGR) of 15.5% during 2022-2027.

Generic injectables refer to drugs that have the same active ingredients, strength, dosage and route of administration as that of branded injectables. In the GCC countries, the demand for injectables is rising as they help to increase patient compliance without compromising the effectiveness of the treatment. Moreover, the lower cost of these injectables, as compared to their branded equivalents, helps in providing substantial savings for both the patients and healthcare providers.

Request for a sample copy of this report: https://www.imarcgroup.com/gcc-generic-injectables-market/requestsample

GCC Generic Injectables Market Trends:

In the GCC region, there has been an rise in the proportion of the geriatric population, due to declining fertility rates and increasing life expectancy. This is expected to boost the sales of the generic injectables across the country for treating the diseases prevalent among the elderly. Furthermore, as the pharmaceutical industry in the GCC region is at a nascent stage, the governments of the countries are focusing on enhancing domestic manufacturing and supplying these drugs at affordable costs. For instance, the Ministry of Health in the UAE is working to increase the number of generic drug manufacturing facilities in the country. Apart from this, several domestic generic injectable manufacturers, particularly in Saudi Arabia, are collaborating with global and regional pharma players to expand their manufacturing capacity.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the GCC generic injectables market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on container type, therapeutic area and distribution channel.

Breakup by Container Type:

• Vials
• Prefilled Syringes
• Ampoules
• Premix
• Others

Vials account for the majority of the total market as they are compact in size, can be reused and are graduated with markings.

Breakup by Therapeutic Area:

• Oncology
• Anaesthesia
• Anti-infectives
• Cardiovascular
• Parenteral Nutrition
• Others

Currently, oncology represents the most popular therapeutic area on account of a rise in cancer diagnosis coupled with improved access to treatment.

Breakup by Distribution Channel:

• Hospitals
• Clinics
• Retail Pharmacy Stores

These injectables are majorly distributed through hospitals as they cannot be traded or administered without medical assistance.

Regional Insights:

• Saudi Arabia
• UAE
• Kuwait
• Qatar
• Oman
• Bahrain

Saudi Arabia represents the leading market within the region. The manufacturers in the country are consistently collaborating with key pharma players for expanding their production capacity.

Competitive Landscape:

The competitive landscape of the market has also been analyzed in the report along with the profiles of key players.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: [email protected]
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal